Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors - Wikidata - awgldk - TriplyDB

Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors

Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors

http://www.wikidata.org/entity/Q28396648

about

Follicle Stimulating Hormone is an accurate predictor of azoospermia in childhood cancer survivors.Antimüllerian hormone levels are lower in BRCA2 mutation carriers.Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.

P2860

Q38669965-C848FD04-77FE-454A-98A1-73CE42B405EF Q40213326-D3516AEE-F0BE-4792-89E0-DF09440271D7 Q47207024-E28D9A9F-F3DB-4393-A5D5-B35A69A9D2E5

P2860

Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors

http://www.wikidata.org/entity/Q28396648

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Self-collected dried blood spo ...... young female cancer survivors

@ast

Self-collected dried blood spo ...... young female cancer survivors

@en

Self-collected dried blood spo ...... young female cancer survivors

@nl

type

label

Self-collected dried blood spo ...... young female cancer survivors

@ast

Self-collected dried blood spo ...... young female cancer survivors

@en

Self-collected dried blood spo ...... young female cancer survivors

@nl

prefLabel

Self-collected dried blood spo ...... young female cancer survivors

@ast

Self-collected dried blood spo ...... young female cancer survivors

@en

Self-collected dried blood spo ...... young female cancer survivors

@nl

P1433

Q28396648-435849F7-29F8-4C10-A09E-0283B75CC970

P1476

Q28396648-282EB562-313F-46CD-96E3-91D1C2866018

P2093

Q28396648-0DF8413D-FCBA-4D6D-A993-13486C531A6C

Q28396648-101FE6A3-C27C-4787-A273-61B5202B3329

Q28396648-2A55A65C-6CFF-4CAA-AE91-2EFF6E1669B5

Q28396648-2DEC4A72-D7D3-4D0A-A13E-735B66F6F37E

Q28396648-4082A6D3-E45B-416F-85D6-B56DFC375AE7

Q28396648-4AD70E1C-55D3-4F5A-87EE-781ACD5418CC

Q28396648-A0ADB034-188F-485B-A3AE-D09468CEB774

P2860

Q28396648-02765966-06F7-40F6-8F2E-DA021522FAA1

Q28396648-040D2AC1-ABB3-41F1-B0E5-B016E18031F5

Q28396648-04660072-FB0E-4007-897A-76DD0836379C

Q28396648-097C10B8-0236-4FDA-A4DA-1692082C5E8F

Q28396648-15FB04A8-8A43-4519-8469-00FCA173F695

Q28396648-1698E898-3221-4163-A961-D605C8A411C1

Q28396648-282E122D-2531-4A28-A9DB-92863D63AA2F

Q28396648-34A0BEDD-9313-4696-995A-B117A9992241

Q28396648-3FD00EDC-E632-4D6F-8122-434AD5139EC0

Q28396648-46016A9C-AF10-4748-893A-82B3E64EB177

P304

Q28396648-6D8AA2CB-8336-442D-9C0A-10D94870BA40

P31

Q28396648-AE7C5460-3C3F-4547-AC81-F3CA77D50FB3

P356

Q28396648-EB236A6E-ECF8-41E8-A0C8-9248C12C0BBE

P407

Q28396648-E5AF9DD8-D54F-4F93-9998-EC757BE59981

P433

Q28396648-3287CF59-32E0-46B3-A764-C414EB44F6D6

P478

Q28396648-8DDD1FB2-E995-4040-80F0-CFA476131CD3

P577

Q28396648-04181906-6657-4062-8060-27EC7924982E

P698

Q28396648-AD4C3C7B-C317-48F6-B6AD-28A918ABA1C5

P921

Q28396648-25DE21F5-86BF-4785-B095-7C3020D0FC88

P932

Q28396648-2A94038E-730A-42E8-9E3E-C6C4E6B3A802

P356

P1433

Human Reproduction

P1476

Self-collected dried blood spo ...... young female cancer survivors

@en

P2093

B W Whitcomb

http://www.w3.org/2001/XMLSchema#string

H I Su

http://www.w3.org/2001/XMLSchema#string

J R Gorman

http://www.w3.org/2001/XMLSchema#string

S A Dominick

http://www.w3.org/2001/XMLSchema#string

S C Roberts

http://www.w3.org/2001/XMLSchema#string

S M Seav

http://www.w3.org/2001/XMLSchema#string

T W McDade

http://www.w3.org/2001/XMLSchema#string

P2860

A validated model of serum anti-müllerian hormone from conception to menopause

Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years

Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy

Impact of cancer therapies on ovarian reserve

Quantification of anti-Müllerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve

Impact of breast cancer on anti-mullerian hormone levels in young women

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors

A Diversified Recruitment Approach Incorporating Social Media Leads to Research Participation Among Young Adult-Aged Female Cancer Survivors.

Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns.

P304

1570-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEW114

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27170433

http://www.w3.org/2001/XMLSchema#string

P921

reproductive medicine

P932

4901885

http://www.w3.org/2001/XMLSchema#string